Navigation Links
DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
Date:3/7/2013

083 represents a 'first in class' small-molecule chemotherapeutic. VAL-083 has been assessed in multiple NCI-sponsored clinical studies in various cancers including lung, brain, cervical, ovarian tumors and leukemia.  Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types.  VAL-083 is approved as a cancer chemotherapeutic in China for the treatment of chronic myelogenous leukemia and lung cancer

Based on published research, the mechanism of action of VAL-083 is understood to be a bi-functional alkylating agent; however, the functional groups associated with alkylating events has been shown to differ from other alkylating agents used in the treatment of GBM.

VAL-083 has previously demonstrated activity in cyclophosphamide, BCNU and phenylanine mustard resistant cell lines and no evidence of cross-resistance has been encountered in published clinical studies.  Based on the presumed alkylating functionality of VAL-083, published literature suggests that DNA repair mechanisms associated with Temodar and nitrosourea resistance, such as 06-methylguanine methyltransferace (MGMT), may not confer resistance to VAL-083. 

VAL-083 readily crosses the blood brain barrier where it maintains a long half-life in comparison to the plasma.  Published preclinical and clinical research demonstrates that VAL-083 is selective for brain tumor tissue.

VAL-083 has been assessed in multiple studies as chemotherapy in the treatment of newly diagnosed and recurrent brain tumors.  In general, tumor regression was achieved following therapy in greater than 40% of patients treated and stabilization was achieved in an additional 20% - 30%.  In published clinical studies, VAL-083 has previously been shown to have a statistically significant impact on median survival in high grade gliomas when combined with radiation vs. radiation alone. 

The mai
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
2. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
4. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
5. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
6. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
7. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
8. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
9. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
10. Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
11. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015   Regulus ... company leading the discovery and development of innovative medicines ... results and highlights for the quarter ended June 30, ... financial markets close. Regulus will host ... 2015, at 5:00 pm Eastern Daylight Time to discuss ...
(Date:7/28/2015)... ST. LOUIS, July 28, 2015  Express Scripts Holding ... net income attributable to Express Scripts stockholders of $600.1 ... diluted share, as detailed in Table 4, were $1.44 ... "It is clear many companies across healthcare are validating ... Chairman and Chief Executive Officer. "But, what matters most ...
(Date:7/28/2015)... PALO ALTO, Calif. , July 28, 2015 /PRNewswire/ ... International Holding Corp., the parent company of CPI International, ... the third quarter ended July 3, 2015 with the ... release regarding its results for the quarter.  At 11 ... hold a telephonic conference call in conjunction with this ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25CPI International To Announce Third Quarter 2015 Financial Results 2
... company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) based company to accelerate the development of new products. , ... , ... ... ...
... March 23 LensAR, Inc., a leading developer ... other ocular applications, today announced the appointment of Michael ... sales and marketing and Ron Goldrich as ... O,Rourke and Mr. Goldrich, who both possess extensive product ...
Cached Medicine Technology:Novalung Records 50% Growth 2Novalung Records 50% Growth 3LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 2LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 3LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 4
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, ... practices, consumer education, resource library, floor plans, educational blog and wide use of ... offers regular posts with valuable links to useful reports by industry experts. Comments ...
(Date:7/28/2015)... ... 28, 2015 , ... Darryl Worley’s Annual Tennessee River Run ... year of raising money for the Darryl Worley Foundation. Worley will host Wade ... concert Saturday, Oct. 3. , This year’s concert will have a second stage ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... United States with 1 in 68 children currently affected with the disorder. For ... child on the road to recovery is extremely daunting. That’s where Talk About ...
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, ... for edge devices that enable the Internet of Things (IoT), announced its new ... processor to provide exceptional computing power and multitasking capabilities. The MLC 4-21 is ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... much-anticipated U.S. commercial launch of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation ... , “OrthAlign successfully combined precision with practicality in a revolutionary way for ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... CHICAGODespite grim prognoses and aggressive treatments, cancer patients suffering ... rate their quality of life more optimistically than their ... School of Medicine study. The research ... up if there is something more to be said, ...
... ... Testifies on Effects of These Head Injuries on Developing Brains , ... Washington, DC (Vocus) May 20, ... Health, Education, Labor, and Pensions Committee of the United States House of Representatives today ...
... ... of Life for Patients, , ... Arlington Heights, IL (Vocus) May 20, 2010 -- Advocating the need for a medical Team ... Surgeons (ASPS), in partnership with the American Society of Breast Surgeons (ASBS), ...
... ,Spare tire, had strongest association with senility, study found ... study suggests that excess fat in the abdomen during ... life. , An estimated 24.3 million people worldwide suffer ... other causes. , In the new study, Dr. Sudha ...
... ... is pleased to announce the hire of Ms. Linda Spooner as Director of Project ... (PRWEB) ... Ms. Linda Spooner as Director of Project Management., , ,Ms. Spooner brings over 10 ...
... defibrillators add more than $4 billion to U.S. health ... -- Costs for patients with chronic heart failure and ... are turning to pricey, surgically implanted devices such as ... , Researchers led by Dr. Peter Groeneveld of Philadelphia ...
Cached Medicine News:Health News:Caregivers of brain cancer patients play a key role 2Health News:Academic Impacts of Concussions for Students at Issue in House of Representatives 2Health News:Academic Impacts of Concussions for Students at Issue in House of Representatives 3Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 2Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 3Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 4Health News:Rapport International Hires Linda Spooner to Lead Project Management 2
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
For quantitative determination of amylase in human serum....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: